You just read:

NCCN Oncology Research Program Awarded $2 Million from Lilly to Study Mechanisms of Resistance to CDK4 & 6 Inhibitors in Breast Cancer Treatment

News provided by

National Comprehensive Cancer Network

Dec 03, 2018, 10:15 ET